首页> 中文期刊> 《中国病理生理杂志》 >HIV相关痴呆的发病机制及药物治疗靶点

HIV相关痴呆的发病机制及药物治疗靶点

         

摘要

HIV - associated dementia ( HAD ) is a serious complication of AIDS patients. With the wide application of highly active antiretroviral therapy ( HAART ), the replication of HIV is under effective control and the incidence of HAD is also declined. However, a relatively mild HIV -associated symptom of dementia, called minor cognitively motor disorder ( MCMD ), become the problem and can not be neglected in the treatment of AIDS. The neural injury caused by HIV may be mediated mainly by macrophages, microglia and astrocytes, though we can not rule out the direct damage on neurons by HIV proteins. To date, the precise mechanism of neural damage caused by HIV remains unclear. The present review tries to figure out the recent progress of pathogenesis and potential drug targets for HAD.%@@ 随着艾滋病(acquired immune deficiency syndrome, AIDS) 的全球性暴发流行,HIV相关神经系统功能障碍,主要为HIV相关痴呆(HIV-associated dementia, HAD)和更加严重的HIV相关神经认知紊乱(HIV-associated neurocognitive disorders, HAND),逐渐被人们所认识并研究.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号